Afrocentric sees growth opportunities in the e-pharm space

PUBLISHED: Mon, 16 Sep 2019 14:51:44 GMT


Investment group Afrocentric released a positive set of results. Headline earnings grew 1.6 per cent in the year ended June 2019 to R265 million. Afrocentric, which invests primarily in the health and pharmaceutical sectors, declared a final dividend of 17 cents. CNBC Africa’s Kopano Gumbi spoke to the CEO, Ahmed Banderker….

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.